Frontage Holdings Corp. 1521

Frontage Laboratories, Inc. ("Frontage"), a leading global CRO/CDMO, is pleased to welcome Dr. Chandra Prakash, Ph.D., as Senior Advisor, Clinical Services. Dr. Prakash is internationally recognized for his scientific leadership in drug metabolism and pharmacokinetics (DMPK), clinical pharmacology, biotransformation, bioanalysis, and translational ADME sciences. Over his 40‑year career, he has made significant contributions to the mechanistic understanding of drug disposition, metabolic pathways

As Asian markets navigate the complexities of rising energy costs and inflationary pressures, investors are increasingly looking for opportunities that offer growth potential at lower entry points. Penny stocks, though an older term, remain relevant today as they often represent smaller or newer companies with untapped potential. By identifying those with strong financials and a promising growth path, investors can uncover valuable opportunities in this segment of the market.

Frontage Laboratories, Inc. ("Frontage"), a leading global CRO/CDMO, today announced the completion of the acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd. ("Teddy Lab"), a leading clinical research laboratory service provider in China. The acquisition aims to enhance Frontage's global laboratory service capabilities and further strengthen its presence in China and the Asia-Pacific region.